Publikationen, an denen er mitarbeitet Manuela Igartua Olaechea (33)

2024

  1. 3D-printed Laponite/Alginate hydrogel-based suppositories for versatile drug loading and release

    Drug Delivery and Translational Research, Vol. 14, Núm. 12, pp. 3385-3403

  2. Laponite nanoclays for the sustained delivery of therapeutic proteins

    European Journal of Pharmaceutical Sciences, Vol. 201

  3. PLGA-PEI nanoparticle covered with poly(I:C) for personalised cancer immunotherapy

    Drug Delivery and Translational Research, Vol. 14, Núm. 10, pp. 2788-2803

2023

  1. Dual ionic interaction blocking/ionic displacement strategy for effective loading and release in 3D printed Alginate-Laponite solid rectal formulations

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  2. Extracellular vesicles released by hair follicle and adipose mesenchymal stromal cells induce comparable neuroprotective and anti-inflammatory effects in primary neuronal and microglial cultures

    Cytotherapy, Vol. 25, Núm. 10, pp. 1027-1032

  3. Soy protein/β-chitin sponge-like scaffolds immobilizing hair follicle and adipose tissue human mesenchymal stromal cells promote chronic wound healing in vivo

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  4. Targeting the central nervous system: From synthetic nanoparticles to extracellular vesicles—Focus on Alzheimer's and Parkinson's disease

    Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, Vol. 15, Núm. 5

  5. Tumour-derived extracellular vesicle based vaccines for melanoma treatment

    Drug Delivery and Translational Research, Vol. 13, Núm. 5, pp. 1520-1542

2022

  1. Alteraciones dermatológicas causadas por las medidas preventivas frente a Covid-19

    Lo que debes saber sobre medicamentos y salud (Grupo Planeta), pp. 77-93

  2. Cell-based dressings: A journey through chronic wound management

    Biomaterials Advances, Vol. 135

  3. Hybrid 3D Printed and Electrospun Multi-Scale Hierarchical Polycaprolactone Scaffolds to Induce Bone Differentiation

    Pharmaceutics, Vol. 14, Núm. 12

  4. Industria farmazeutikoak ingurumenean duen inpaktua murrizteko estrategiak

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 42, pp. 49-71

2021

  1. Characterization of bio-inspired electro-conductive soy protein films

    Polymers, Vol. 13, Núm. 3, pp. 1-15

  2. Comparison of size and protein decoration between extracellular vesicles isolated from adipose tissue and hair follicle mesenchymal stem cells

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 189-190

  3. Formulation of a 3D printable hydrogel for the development of solid rectal drug delivery system

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 213-215

  4. Latest advances to enhance the therapeutic potential of mesenchymal stromal cells for the treatment of immune-mediated diseases

    Drug Delivery and Translational Research, Vol. 11, Núm. 2, pp. 498-514

  5. Polycaprolactone hybrid scaffolds combining 3D printing and electrospinning to guide the osteogenic differentiation of MC3T3 preosteoblasts for bone tissue regeneration

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 30-32

2020

  1. 3D encapsulation and inflammatory licensing of mesenchymal stromal cells alter the expression of common reference genes used in real-time RT-qPCR

    Biomaterials Science, Vol. 8, Núm. 23, pp. 6741-6753

  2. Chronic wounds: Current status, available strategies and emerging therapeutic solutions

    Journal of Controlled Release, Vol. 328, pp. 532-550

  3. Mesenchymal stromal cell based therapies for the treatment of immune disorders: recent milestones and future challenges

    Expert Opinion on Drug Delivery, Vol. 17, Núm. 2, pp. 189-200